How AI is revolutionising drug industry by cutting pharmaceutical development time

Zhavoronkov says AI can speed up and reduce costs for drug development which – involving several phases of clinical trials, government approval and licensing – can last more than a decade. "Moving to Hong Kong [which is a special administrative region of China] is the first step for us to go to China. The future for AI is in China as AI is about data and China has more data than any other country. The [Chinese] government also supports AI more than any other country," he says. "Hong Kong also has a great banking system and a great airport for you to fly pretty much everywhere in the world."